AntibioticsINJECTIONGeneric
BICILLIN L-A
PENICILLIN G BENZATHINE
Standard Dose
300,000 UNITS/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary
Approval overview BICILLIN L-A is listed in Drugs@FDA under application 050141 (NDA).
Review priority: N/A Marketing status: Discontinued Active ingredient PENICILLIN G BENZATHINE Form and strength INJECTABLE;INJECTION - 300,000 UNITS/ML Sponsor KING PHARMS LLC Submission history Latest submission status date: 2021-01-25 00:00:00.
Structured Monograph
Clinical summary
Approval overview BICILLIN L-A is listed in Drugs@FDA under application 050141 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient PENICILLIN G BENZATHINE Form and strength INJECTABLE;INJECTION - 300,000 UNITS/ML Sponsor KING PHARMS LLC Submission history Latest submission status date: 2021-01-25 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.